Table 1.
Variables | Event-Free Survival | Overall Survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
Univariate Analysis | ||||||
FXIII-A expression pattern | ||||||
FXIII-A negative | 2.91 | 1.17–7.21 | 0.021 | 2.63 | 0.88–7.84 | 0.084 |
FXIII-A dim | 0.34 | 0.14–0.85 | 0.38 | 0.13–1.14 | ||
Age | ||||||
1–5 years | 0.39 | 0.17–0.92 | 0.032 | 0.24 | 0.08–0.71 | 0.010 |
≥6 years | 2.56 | 1.10–6.05 | 4.20 | 1.41–12.56 | ||
WBC | ||||||
<20,000 | 0.69 | 0.29–1.66 | 0.407 | 0.60 | 0.21–1.71 | 0.334 |
≥20,000 | 1.45 | 0.60–3.51 | 1.69 | 0.58–4.86 | ||
Sex | ||||||
Male | 1.53 | 0.62–3.79 | 0.360 | 1.87 | 0.59–6.00 | 0.291 |
Female | 0.65 | 0.26–1.62 | 0.54 | 0.17–1.71 | ||
prednisone response | ||||||
PGR | 0.27 | 0.09–0.73 | 0.010 | 0.15 | 0.05–0.45 | 0.001 |
PPR | 3.75 | 1.37–10.24 | 6.71 | 2.25–20.03 | ||
FC risk categories | ||||||
FLR/FMR | 1.43 | 0.40–5.13 | 0.581 | 1.18 | 0.25–5.54 | 0.838 |
FLR/FHR | 3.37 | 0.78–14.58 | 0.104 | 3.40 | 0.62–18.56 | 0.158 |
ALLIC BFM 2009 classification | ||||||
BFM-HR/BFM-SR | 0.12 | 0.01–0.95 | 0.044 | 0.00 | ||
BFM-HR/BFM-IR | 0.41 | 0.16–1.05 | 0.063 | 0.32 | 0.11–0.92 | 0.035 |
Genetic risk categories | ||||||
good/intermediate | 7.12 | 2.07–24.73 | 0.002 | 13.8 | 1.77–107.9 | 0.012 |
good/high | 23.7 | 4.72–119.3 | <0.001 | 63.1 | 6.50–613.3 | <0.001 |
B-other | ||||||
Recurrent genetic abnormalities | 0.26 | 0.10–0.68 | 0.006 | 0.27 | 0.08–0.86 | 0.027 |
B-other | 3.82 | 1.48–9.86 | 3.71 | 1.16–11.85 | ||
Multivariate Analysis | ||||||
FXIII negative | 2.29 | 0.85–6.20 | 0.102 | 1.70 | 0.51–5.71 | 0.390 |
Genetic risk categories | ||||||
good/intermediate | 5.78 | 1.63–20.52 | 0.007 | 10.0 | 1.24–81.4 | 0.031 |
good/high | 17.4 | 2.88–104.8 | 0.002 | 30.5 | 2.63–353.4 | 0.006 |
p < 0.05 values were considered statistically significant, such p values are marked in bold.